SG53130A1 - Pyridine derivatives process for preparing the same and intermediate therefor - Google Patents

Pyridine derivatives process for preparing the same and intermediate therefor

Info

Publication number
SG53130A1
SG53130A1 SG1997004224A SG1997004224A SG53130A1 SG 53130 A1 SG53130 A1 SG 53130A1 SG 1997004224 A SG1997004224 A SG 1997004224A SG 1997004224 A SG1997004224 A SG 1997004224A SG 53130 A1 SG53130 A1 SG 53130A1
Authority
SG
Singapore
Prior art keywords
protected
unprotected
preparing
same
pyridine derivatives
Prior art date
Application number
SG1997004224A
Other languages
English (en)
Inventor
Tatsuzo Ukita
Masakatsu Sugahara
Katsuo Ikezawa
Hideo Kikkawa
Kazuaki Naito
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of SG53130A1 publication Critical patent/SG53130A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Seasonings (AREA)
  • Press Drives And Press Lines (AREA)
SG1997004224A 1996-12-13 1997-12-02 Pyridine derivatives process for preparing the same and intermediate therefor SG53130A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP33335796 1996-12-13

Publications (1)

Publication Number Publication Date
SG53130A1 true SG53130A1 (en) 1998-09-28

Family

ID=18265214

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1997004224A SG53130A1 (en) 1996-12-13 1997-12-02 Pyridine derivatives process for preparing the same and intermediate therefor

Country Status (14)

Country Link
US (1) US5965730A (fr)
EP (1) EP0848000B1 (fr)
KR (1) KR100416833B1 (fr)
CN (1) CN1127498C (fr)
AT (1) ATE219075T1 (fr)
CA (1) CA2224635C (fr)
DE (1) DE69713255T2 (fr)
DK (1) DK0848000T3 (fr)
ES (1) ES2178741T3 (fr)
HK (1) HK1012505A1 (fr)
ID (1) ID19155A (fr)
PT (1) PT848000E (fr)
SG (1) SG53130A1 (fr)
TW (1) TW429257B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1302677B1 (it) * 1998-10-15 2000-09-29 Zambon Spa Derivati benzazinici inibitori della fosfodiesterasi 4
MXPA01008178A (es) * 1999-02-18 2002-03-13 Hoffmann La Roche Derivados de fenilalaninol.
MXPA02001830A (es) 1999-08-21 2002-08-12 Byk Gulden Lomberg Chem Fab Combinacion sinergica de inhibidores de pde y agonista de beta 2 adrenoceptor.
EP2258689A1 (fr) * 2000-03-16 2010-12-08 Biolipox AB Inhibiteurs benzyles de PDE4
AR029289A1 (es) 2000-07-05 2003-06-18 Ishihara Sangyo Kaisha Derivado de benzoilpiridina o su sal, fungicida que lo contiene como un ingrediente activo, su proceso de produccion e intermediario para producirlo
JP4510384B2 (ja) * 2001-05-23 2010-07-21 田辺三菱製薬株式会社 骨折治癒促進用組成物
ES2427930T3 (es) 2001-05-23 2013-11-04 Mitsubishi Tanabe Pharma Corporation Composición terapéutica para el tratamiento regenerativo de enfermedades de los cartílagos
WO2003057689A1 (fr) * 2002-01-02 2003-07-17 Fujisawa Pharmaceutical Co., Ltd. Composes aminopyrimidine, procedes de preparation de ces composes et compositions pharmaceutiques les contenant
EA200501548A1 (ru) 2003-04-01 2006-02-24 Апплайд Резеч Системз Арс Холдинг Н.В. Ингибиторы фосфодиэстераз при бесплодии
CA2539479C (fr) * 2003-09-23 2010-07-06 Merck & Co., Inc. Inhibiteurs des canaux potassiques a l'isoquinoleine
TWI339578B (en) * 2004-10-29 2011-04-01 Mitsubishi Tanabe Pharma Corp Use of a pyridine compound for the preparation of a medicament for the treatment of skin lesions
CN101277697A (zh) * 2005-10-05 2008-10-01 田边三菱制药株式会社 皮炎治疗剂
MX2008010953A (es) * 2006-02-28 2008-09-08 Amgen Inc Derivados de cinolina y quinoxalina como inhibidores de la fosfodiesterasa 10.
ES2466565T3 (es) 2008-08-06 2014-06-10 Biomarin Pharmaceutical Inc. Inhibidores dihidropiridoftalazinona de poli(ADP-ribosa)polimerasa (PARP)
WO2011097334A1 (fr) 2010-02-03 2011-08-11 Biomarin Pharmaceutical Inc. Inhibiteurs à base de dihydropyridophtalazinone de la poly(adp-ribose) polymérase (parp) utilisables dans le cadre du traitement de maladies associées à un déficit en pten
EP2533640B1 (fr) 2010-02-08 2016-09-28 Medivation Technologies, Inc. Procédés de synthèse de dérivés de dihydropyridophtalazinone
RU2438672C1 (ru) * 2010-04-30 2012-01-10 Общество с ограниченной ответственностью "Клевер Фарм" Агент, проявляющий свойства активатора когнитивных функций (варианты)
CA2814581C (fr) 2010-10-21 2019-02-12 Biomarin Pharmaceutical Inc. Sel tosylate de la (8s,9r)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1h- 1,2,4-triazol-5-yl)-8,9-dihydro-2h-pyrido[4,3,2-de]phtalazin-3(7h)-one cristallin
ES2968010T3 (es) * 2015-09-02 2024-05-06 Basf Se Composición lubricante
CN108658937A (zh) * 2017-03-28 2018-10-16 中国海洋大学 一种双环生物碱类化合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9027055D0 (en) * 1990-12-13 1991-02-06 Sandoz Ltd Organic compounds
JP3042156B2 (ja) * 1992-02-20 2000-05-15 田辺製薬株式会社 ナフタレン誘導体、その製法及びその合成中間体
GB9322828D0 (en) * 1993-11-05 1993-12-22 Sandoz Ltd Organic compounds
IL118469A (en) * 1995-06-15 2000-08-13 Tanabe Seiyaku Co Naphthalene derivatives their preparation and intermediates thereof

Also Published As

Publication number Publication date
CN1184813A (zh) 1998-06-17
US5965730A (en) 1999-10-12
ID19155A (id) 1998-06-18
CA2224635C (fr) 2006-01-31
DK0848000T3 (da) 2002-09-30
EP0848000A1 (fr) 1998-06-17
KR19980064040A (ko) 1998-10-07
ATE219075T1 (de) 2002-06-15
DE69713255T2 (de) 2002-11-07
MX9710182A (es) 1998-10-31
PT848000E (pt) 2002-09-30
TW429257B (en) 2001-04-11
EP0848000B1 (fr) 2002-06-12
HK1012505A1 (en) 1999-08-06
ES2178741T3 (es) 2003-01-01
CN1127498C (zh) 2003-11-12
KR100416833B1 (ko) 2004-05-24
CA2224635A1 (fr) 1998-06-13
DE69713255D1 (de) 2002-07-18

Similar Documents

Publication Publication Date Title
SG53130A1 (en) Pyridine derivatives process for preparing the same and intermediate therefor
MY121606A (en) Naphthalene derivatives, process for the preparation thereof, and intermediates therefor and pharmaceutical compositions comprising them
ES2090855T3 (es) Derivados de naftaleno, procedimientos para su preparacion y productos intermediarios apropiados.
EP0989129A4 (fr) Derives de pyrazolopyridylpyridazinone et procede de preparation des ces derniers
GR3033594T3 (en) Hypoglycemic dihydrochalcone derivatives.
HK1040513A1 (en) 1-acetyl-5-bromo-4, 6-dimethylindoline
AU6601294A (en) Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses
AU689304B2 (en) Quinazoline derivative
NZ229347A (en) Substituted cephalosporin derivatives; pharmaceutical compositions, preparatory processes and intermediates
IL130052A0 (en) Method of treating glaucoma and ischemic retinopathy
AU3386093A (en) Tetrahydrothiophene derivatives
HK1067948A1 (en) Antitumor indolopyprolocarbazole derivative
DK0682023T3 (da) Imidazopyridinderivater og fremgangsmåde til fremstilling deraf
HUT66964A (en) Substituted pyrido-pyrimidine derivatives and pharmaceutical compositions containing them